Why Patients Seek a Second Opinion for GBM Surgery
Glioblastoma (GBM) is the most common aggressive primary brain tumor. Patients often seek a second opinion on surgery to confirm the recommended resection plan, surgeon experience, and hospital volume. A second opinion can affect the extent of safe tumor removal, which directly influences progression-free survival and quality of life. Leading cancer centers publish data showing that high-volume neurosurgical teams achieve more complete resections with fewer complications.
Insurance and hospital networks in the United States typically cover second opinion consultations for cancer surgery. Patients can request records, imaging, and pathology slides before the appointment. Many academic neuro-oncology programs offer formal second opinion pathways for GBM, including remote review of MRI scans and operative plans. This process helps patients compare surgical strategies such as awake craniotomy, intraoperative MRI, and fluorescence-guided resection.
Top Hospitals and Surgeons for GBM Surgery Second Opinions
Several U.S. hospitals are ranked highly for neurosurgery and brain tumor care in national surveys. Institutions such as MD Anderson Cancer Center, Mayo Clinic, Memorial Sloan Kettering Cancer Center, and Cleveland Clinic have dedicated neuro-oncology programs that accept second opinion referrals for GBM surgery. These centers publish outcomes data, surgeon credentials, and case volumes that patients can review before scheduling.
Patients can use hospital websites, physician directories, and peer-reviewed data to compare GBM surgery outcomes. Factors to check include the surgeon's fellowship training in brain tumor surgery, annual case volume, use of intraoperative mapping, and hospital accreditation for brain tumor programs. Some centers also provide remote second opinion services, where patients submit imaging and medical records for a written or video consultation without traveling.
What to Expect During a Second Opinion Review for GBM Surgery
A second opinion review typically starts with a neuro-oncology team evaluating preoperative MRI, pathology reports, and the original surgical plan. The team may include a neurosurgeon, neuro-oncologist, radiation oncologist, and neuroradiologist. They assess whether the recommended approach aligns with current guidelines and published data on maximal safe resection.
After the review, patients receive a written summary that may confirm, modify, or suggest alternatives to the original surgical plan. Common alternatives include biopsy-only procedures, awake craniotomy with mapping, or referral for clinical trials combining surgery with tumor-treating fields or immunotherapy. Patients can use this information to discuss options with their local care team and decide on next steps.